PVR and cancer: As shown in Table 2, increased CD155 expression was found to be significantly associated with reduced OS in patients with cancer as compared to low CD155 expression (pooled HR = 1.772, 95% CI = 1.441–2.178, P < 0.001, Fig. 2).